Related Experiment Video
Updated: Sep 13, 2025

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
Dopamine D2/D3 receptor availability and working memory in stimulant use disorder.
Andy C Dean1,2, Daicia Allen1, Megan McClintick1
1Department of Psychiatry and Biobehavioral Sciences, UCLA Semel Institute for Neuroscience, David Geffen School of Medicine, Los Angeles, CA, USA.
Working memory deficits in stimulant use disorder are linked to lower dopamine D2/3 receptor availability in the brain. Improving dopamine signaling may boost cognitive function and treatment outcomes.
Area of Science:
- Neuroscience
- Psychiatry
- Addiction Medicine
Background:
- Dopaminergic neurochemical markers correlate with working memory in healthy individuals and schizophrenia patients.
- Individuals with stimulant use disorder exhibit reduced dopaminergic markers, including striatal D2/3 receptor availability, and impaired working memory.
Purpose of the Study:
- To investigate the relationship between working memory performance and D2/3 receptor availability in individuals with stimulant use disorder.
- To inform the development of targeted treatments for stimulant use disorder.
Main Methods:
- Eighty-four adults with stimulant use disorder and 47 controls completed the Spatial Capacity Delayed Response Task (SCAP) for working memory assessment.
- A subset of the stimulant use disorder group (n=52) underwent positron emission tomography (PET) using [18F]fallypride to measure D2/3 receptor availability.
- Correlations between SCAP performance and D2/3 receptor availability were analyzed in key cortical regions.
Main Results:
- Participants with stimulant use disorder showed significantly poorer performance on the SCAP compared to controls, even after controlling for demographics and intelligence.
- In the stimulant group, SCAP performance positively correlated with D2/3 receptor availability in the cingulate cortex (p < .013).
Conclusions:
- The observed working memory deficits in stimulant use disorder are associated with reduced cortical D2/3 receptor signaling.
- Therapeutic strategies aimed at enhancing cortical D2/3 receptor signaling could potentially improve cognitive function and treatment response in this population.
More Related Videos
07:25Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Abuse and Addiction: Pharmacological Phenomena
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Affecting Neurotransmitter Release or Uptake